Filing Details

Accession Number:
0000899243-15-003409
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-08-18 16:05:47
Reporting Period:
2015-08-14
Filing Date:
2015-08-18
Accepted Time:
2015-08-18 16:05:47
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1512762 Coherus Biosciences Inc. CHRS Biological Products, (No Disgnostic Substances) (2836) 273615821
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1459154 Mats Wahlstrom C/O Coherus Biosciences, Inc.
201 Redwood Shores Parkway, Suite 200
Redwood City CA 94065
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, $0.0001 Par Value Disposition 2015-08-14 116,554 $34.24 592,928 No 4 S Indirect See Footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect See Footnote
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock, $0.0001 Par Value 53,583 Indirect See Footnote
Footnotes
  1. The transaction was executed in multiple trades in prices ranging from $33.68 to $34.50, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected.
  2. The shares are held by KMG Capital Partners, LLC. Mr. Wahlstrom disclaims beneficial ownership of the shares held by KMG Capital Partners, LLC except to the extent of his pecuniary interest therein.
  3. The shares are held by Leonard Capital, LLC. Mr. Wahlstrom disclaims beneficial ownership of the shares held by Leonard Capital, LLC except to the extent of his pecuniary interest therein.